Growth and growth hormone status following treatment for childhood leukaemia

Hormone Research

Volumn 50, Issue 1, 1998, Pages 1-10

  Shalet, S M ^a   Brennan, B M D ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Growth; Growth hormone; Leukaemia; Radiotherapy

Indexed keywords

ANTILEUKEMIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; GROWTH HORMONE; MERCAPTOPURINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE DYSPLASIA; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILDHOOD LEUKEMIA; GRAFT VERSUS HOST REACTION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RETARDATION; HORMONE SUBSTITUTION; HUMAN; PRIORITY JOURNAL; REVIEW; SKULL IRRADIATION;

ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; LEUKEMIA; RADIOTHERAPY; WHOLE-BODY IRRADIATION;

EID: 0031859362     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023193     Document Type: Review

References (62)

1. Davies HA, Didcock E, Didi M, Ogilvy-Stuart A, Wales JKH, Shalet SM: Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia. Arch Dis Child 1994;70:472-475.
2. Kirk J, Raghupathy P, Stevens MM. Cowell CT, Menser MA, Bergin M, Tink A, Vines RH, Silink M: Growth failure and growth hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1987;i:190-193.
3. Clayton PE, Shalet SM, Morris-Jones PM, Price DA: Growth in children treated for acute lymphoblastic leukaemia. Lancet 1988;i:460-462.
4. Price D, Morris M, Rowsell K, Jones P: The effects of anti-leukaemic drugs on somatomedin production and cartilage responsiveness to somatomedin in vitro. Pediatr Res 1981;15: 1553.
5. Green D, Williams P, Simpson L, Blunenson L, Murphy G: Evaluation of the chronic hepatic toxicity of 6-mercaptopurine in the Wistar rat. Oncology 1983;40:138-142.
6. Bar-On E, Beckwith JB, Odom LF, Eilert RE: Effect of chemotherapy on the human growth plate. Pediatr Orthop 1993;13:220-224.
7. Ahmed SF, Wallace WHB, Kelnar CJH: An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia. Horm Res 1997;48:178-183.
8. Crofton PM, Ahmed SF, Wade JC, Ranke MB, Wallace WHB, Kelnar CJH: Growth markers during intensive chemotherapy in children with acute lymphoblastic leukaemia. Horm Res 1997;48(suppl2):62.
9. Romain J, Villaizan CJ, Garcia-Foncillas J, Azcona C, Salvador J, Sierrasesumaga L: Chemotherapy-induced growth hormone deficiency in children with cancer. Med Pediatr Oncol 1995; 25:90-95.
10. Sklar C, Mertens A, Walter A, Mitchell D, Nesbit M, O'Leary M, Hutchinson R, Meadows A, Robison L: Final height after treatment for childhood acute lymphoblastic leukaemia: Comparison of no cranial irradiation with 1,800 and 2,400 cGy cranial irradiation. J Pediatr 1993;123:59-64.
11. Holm K, Nysom K, Hertz H, Muller J: Normal final height after treatment for acute lymphoblastic leukemia without irradiation. Acta Paediatr Scand 1994;83:1287-1290.
12. Hokken-Koelega ACS, Doom JWD, Hahlen K, Stijnen T, Muinck Keizer-Schrama SMPF, Drop SLS: Longterm effects of treatment for acute lymphoblastic leukaemia with and without cranial irradiation on growth and puberty: A comparative study. Pediatr Res 1993;33: 577-582.
13. Katz JA, Chambers B, Everhart C, Marks JF, Buchanan GR: Linear growth in children with acute lymphoblastic leukemia treated without cranial irradiation. J Pediatr 1991;118:575-578.
14. Didcock E, Davies HA. Didi M, Ogilvy-Stuart AL, Wales JKH, Shalet SM: Pubertal growth in young adult survivors of childhood leukemia. J Clin Oncol 1995;13:2503-2507.
15. Quigley C, Cowell C, Jimenez M, Burger H, Kirk J, Bergin M, Stevens M, Simpson J, Silink M: Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukaemia. N Engl J Med 1989;321:143-151.
16. Crowne EC, Wallace WHB, Gibson S, Moore CM, White A, Shalet SM: Adrenocorticotrophin and cortisol secrelion in children after low dose cranial irradiation. Clin Endocrinol (Oxf) 1993;39:297-305.
17. Wallace WHB, Shalet SM, Lendon M, Morris Jones PH: Male fertility in longterm survivors of childhood acute lymphoblastic leukaemia. Int J Androl 1991;14:312-319.
18. Lannering B, Jansson C, Rosberg S, Albertsson-Wikland K: Increased LH and FSH secretion after cranial irradiation in boys. Med Pediatr Oncol 1997;29:280-287.
19. Crowne EC, Moore C, Wallace WHB, Morris Jones PH, Shalet SM: A novel variant of growth hormone (GH) insufficiency following low dose cranial irradiation. Clin Endocrinol (Oxf) 1992;36:59-68.
20. Lannering B, Rosberg S, Marky I, Moell C, Albertsson-Wikland K: Reduced growth hormone secretion with maintained periodicity following cranial irradiation in children with acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 1995;42:153-159.
21. Melin AE, Souberbielle JC, Leverger G, Schaison G, Verber F, Brauner R: Growth hormone (GH) peak, plasma IGF-I and growth after irradiation with 18 Gy for leukemia. Horm Res 1996;46(suppl2):37.
22. Cicognani A, Cacciari E, Carla G, Rosito P, Cau M, Mancini A, Zucchini S, Vecchi V, Pirazolli P, Paolucci G: Magnetic resonance imaging of the pituitary area in children treated for acute lymphoblastic leukemia with low dose (18 Gy) cranial irradiation. Am J Dis Child 1992;146:1343-1348.
23. Talvensaari KK, Lanning M, Paakko E, Tapanainen P, Knip M: Pituitary size assessed with magnetic resonance imaging as a measure of growth hormone secretion in long term survivors of childhood cancer. J Clin Endocrinol Metab 1994;79:1122-1127.
24. Brennan BMD, Rahim A, Mackie EM, Eden OB, Shalet SM: Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf). in press.
25. Toogood AA, Ryder D, Beardwell CG, Shalet SM: The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status. Clin Endocrinol (Oxf) 1995;43:97-103.
26. Shalet SM, Toogood AA, Rahim A, Brennan BMD: The diagnosis of growth hormone deficiency in children and adults. Endocr Rev, in press.
27. Rosenfeld RG. Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, Lafranchi S, Lippe B, Loriaux L, Melmed S, Preece MA, Ranke MB, Reiter EO, Rogol AD, Underwood LE, Werther GA: Diagnostic controversy: The diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995;80:1532-1540.
28. DeBoer H, Blok GJ, Van der Veen EA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63-86.
29. Sklar C, Sarafoglou K, Whittam E: Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol (Copenh) 1993;129:511-515.
30. Tillman V, Buckler JMH, Kibirige MS, Price DA, Shalet SM, Wales JKH, Addison MG, Gill MS, Whatmore AJ, Clayton PE: Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 1997;82:531-535.
31. Didi M, Brennan BMD, Shalet SM: Growth hormone replacement in children treated for leukaemia in childhood. Horm Res 1997; 48(suppl 2):65.
32. Adan L, Souberbielle JC, Blanche S, Leverger G, Schaison G, Brauner R: Adult height after cranial irradiation with 24 Gy: Factors and markers of height loss. Acta Paediatr Scand 1996;86:1096-1101.
33. Adan L, Souberbielle JC, Zucker JM, Pierre-Kahn A, Kalifa C, Brauner R: Adult height in 24 patients treated for growth hormone deficiency and early puberty. J Clin Endocrinol Metab 1997;82:229-233.
34. Wilton P: Safety of growth hormone: Value of a large data base. Clin Pediatr Endocrinol 1994; 3(suppl 5):61-71.
35. Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfeld R: Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience. J Clin Endocrinol Metab 1996;81:1704-1710.
36. Leiper A: Growth hormone deficiency in children treated for leukaemia. Acta Paediatr Scand 1995;84(suppl 411):41-44.
37. Ogilvy-Stuart AL, Ryder WDJ, Gattamaneni HR, Clayton PE, Shalet SM: Growth hormone and tumour recurrence. BMJ 1992;304:1601-1605.
38. Giorgiani G, Bozzola M, Locatelli F, Picco P, Zecca M, Cistemino M, Dallorso S, Bonetti F, Dini G, Borrone C, Regazzi MB, DeStefano P, Seven F: Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recomhinant human growth hormone. Blood 1995;86:825-831.
39. Huma Z, Boulad F, Black P, Heller G, Sklar C: Growth in children after bone marrow transplantation for acute leukemia. Blood 1995;86: 819-824.
40. Sullivan KM, Deeg HJ, Sanders JE, Shulman HM, Witherspoon RP, Doney K, Appelbaum FR, Schubert MM, Stewart P, Springmeyer S: Late complications after marrow transplantation. Semin Hematol 1984;21:53-63.
41. Clement-De Boers A, Oostdijk W, Van Weel-Sipman MH, Van Den Broeck J, Wit JM, Vossen JM: Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996;129:544-550.
42. Bushhouse S, Ramsay NKC, Pescovitz OH, Kim T, Robison LL: Growth in children following irradiation for bone marrow transplantation. Am J Pediatr Hematol Oncol 1989;11: 134-140.
43. Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP, Deeg HJ, Doney KC, Sullivan KM, Appelbaum FR, Storb R, Thomas ED: Growth and development following marrow transplantation for leukaemia. Blood 1986;68:1129-1135.
44. Leiper AD, Stanhope R, Lau T, Grant DB, Blacklock H, Chessells JM, Plowman PN: The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 1987;67:419-426.
45. Thomas BC, Stanhope R, Plowman PN, Leiper AD: Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 1993;152: 888-892.
46. Brauner R, Fontoura M, Zucker JM, Devergie A, Souberbielle JC, Prevot-Saucet C, Michon J, Gluckman E, Griscelli C, Fischer A, Rappaport R: Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 1993;68:458-463.
47. Wingard JR, Plotnick NP, Freemer CS, Zahurak M, Piantadosi S, Miller DF, Vrisendorp HM, Yeager AM, Santos GW: Growth in children after bone marrow transplantation: Busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 1992;79:1068-1072.
48. Sanders JE: Growth and development after bone marrow transplantation; in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. London, Blackwell, 1994, pp 527-537.
49. Manenti F, Galimberti M, Lucarelli G: Growth and endocrine function after bone marrow transplantation for thalassemia; in Buckner CD, Gale RP, Lucarelli G (eds): Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches. New York, Liss, 1989, pp 273-280.
50. Liesner RJ, Leiper AD, Hann IM, Chessells JM: Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 1994;12:916-924.
51. Willi SM, Cooke K, Goldwein J, August CS, Olshan JS, Moshang T: Growth in children after bone marrow transplantation for leukaemia or aplastic anaemia. J Pediatr 1992; 120:726-732.
52. Brauner R, Adan L, Souberbielle JC, Esperou H, Michon J, Devergie A, Gluckman E, Zucker JM: Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997;130:785-792.
53. Sanders JE, Buckner CD, Sullivan KM, Doney K, Appelbaum F, Witherspoon R, Storb R, Thomas ED: Growth and development in children after bone marrow transplantation. Horm Res 1988;30:92-97.
54. Papadimitriou A, Uruena M, Hamill G, Stanhope R, Leiper AD: Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Child 1991;66:689-692.
55. Borgstrom B, Bolme P: Growth and growth hormone in children after bone marrow transplantation. Horm Res 1988;30:98-100.
56. Ogilvy-Stuart AL, Clark DJ, Wallace WHB, Gibson BE, Stevens RF, Shalet SM, Donaldson MDC: Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992;67: 1107-1110.
57. Olshan JS, Willi SM, Gruccio D, Moshang T: Growth hormone function and treatment following bone marrow transplant for neuroblastoma. Bone Marrow Transplant 1993;12:381-385.
58. Hovi L, Rajantie J, Perkkio M, Sainio K, Sipila I, Siimes MA: Growth failure and growth hormone deficiency in children after bone marrow transplantation for leukaemia. Bone Marrow Transplant 1990;5:183-186.
59. Thomas BC, Stanhope R, Plowman PN, Leiper AD: Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol (Copenh) 1993;128:508-512.
60. Littley MD, Shalet SM, Morgenstern GR, Deakin DP: Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q J Med 1991;287:265-274.
61. Rochiccioli P, Tauber M: Growth hormone deficiency: Establishment of the diagnosis by means of growth hormone secretion tests in the Kabi International Growth Study: in Ranke MB, Gunnarsson R (eds): Progress in Growth Hormone Therapy - 5 Years of Kigs. Mannheim, Verlag Mannheim, 1994, pp 68-76.
62. Cohen A, Rovelli A, Van-Lint MT, Uderzo C, Morchio A, Pezzini C, Masera G, Bacigalupo A, Romano C: Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Child 1996;74:437-440.